Clinical Trial Update: Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on preemptive lung impedance-guided therapy in evolving acute heart failure following acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Heart Failure | Phase 3 | Status: COMPLETED